Skip to content

SCHEDULE 13D/AAccepted Feb 17, 8:11 PM ET

Bolt Biotherapeutics, Inc. SCHEDULE 13D/A

Pivotal bioVenture Partners Fund I, L.P.

Accepted (ET)

8:11 PM

Feb 17, 2026

Filed

Feb 17, 2026

Documents

2

Size

58.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.